Latest News and Press Releases

FORESIGHT TECHNOLOGY VCT PLCLEI: 21380013CXOR8N6OD97722 July 2026 Final results31 March 2026 Foresight Technology VCT Plc, managed by Foresight Group LLP, today announces the final results for the...

EpicQuest Education announced the beta testing of its AI tutoring platform for its Davis University and Davis Academy students.

VANCOUVER, British Columbia, July 20, 2026 (GLOBE NEWSWIRE) -- Li-FT Power Ltd. (“LIFT” or the “Company”) (TSXV: LIFT) (ASX: LFT) (OTCQX: LIFFF) (Frankfurt: WS0) is pleased to announce the...

Check-Cap ($MBAI) merger partner MBody AI added multi-robot fleet control to its proprietary AI-driven MBody AI Orchestrator platform.

PHILADELPHIA, July 16, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development...

AUSTIN, Texas, July 15, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: When people talk about the AI buildout, they tend to reach for the same shorthand: chips. But the more instructive...

Check-Cap ($MBAI): MBody AI signed a referral/channel deal with Buyers Edge, expanding access to ~286,000 operator, manufacturer & distributor locations.

Avere Therapeutics’ lead program, AVR-001, is a differentiated oral peptide interleukin-23 (IL-23) receptor antagonist, with Phase 1b psoriasis data supporting its potential to be rapidly developed as...

AUSTIN, Texas, July 13, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: The AI buildout is usually described in one word: chips. But the more revealing story may be happening downstream in...

Chemomab and Scipher announced a merger agreement to advance nebokitug into a Phase 2 precision medicine trial for the treatment of rheumatoid arthritis.